Cargando…

Central Nervous System Involvement in Patients with Diffuse Large B Cell Lymphoma: Analysis of the Risk Factors and Prognosis from a Single-Center Retrospective Cohort Study

PURPOSE: The aim of this study was to identify the risk factors for central nervous system (CNS) involvement in systemic diffuse large B-cell lymphoma (DLBCL) patients and to explore prognostic for DLBCL patients with CNS involvement (relapse or progression). PATIENTS AND METHODS: This was a retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Jingjing, Li, Qing, Shao, Jie, Ma, Yan, Lin, Zhiguang, Kang, Hui, Chen, Bobin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896928/ https://www.ncbi.nlm.nih.gov/pubmed/31819650 http://dx.doi.org/10.2147/CMAR.S225372

Ejemplares similares

High Level of IL-10 in Cerebrospinal Fluid is Specific for Diagnosis of Primary Central Nervous System Lymphoma
por: Shao, Jie, et al.
Publicado: (2020)

Prognostic impact of peripheral natural killer cells in primary central nervous system lymphoma
por: Lin, Zhiguang, et al.
Publicado: (2023)

P1143: ZANUBRUTINIB PLUS CYTARABINE IN PATIENTS WITH REFRACTORY/RELAPSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
por: Lin, Zhiguang, et al.
Publicado: (2023)

Radiotherapy or chemotherapy: a real-world study of the first-time relapsed and refractory primary central nervous system lymphoma
por: Yang, Yu, et al.
Publicado: (2023)

Improvement of outcomes of an escalated high‐dose methotrexate-based regimen for patients with newly diagnosed primary central nervous system lymphoma: a real-world cohort study
por: Li, Qing, et al.
Publicado: (2021)

Pemetrexed Plus Lenalidomide for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Prospective Single-Arm Phase II Study
por: Ma, Jingjing, et al.
Publicado: (2022)

Cerebrospinal fluid metabolic markers predict prognosis behavior of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatment
por: Zhou, Liying, et al.
Publicado: (2022)

Central nervous system involvement of primary renal lymphoma with diffuse large B-cell type lymphoma
por: Hu, Rong, et al.
Publicado: (2013)

Methotrexate plus idarubicin improves outcome of patients with primary central nervous system lymphoma
por: Fan, Ni, et al.
Publicado: (2017)

The Outcomes of Diffuse Large B-cell Lymphoma Patients with Synchronous and Early Central Nervous System Involvement: A Single-Center Experience
por: Al-Mansour, Mubarak, et al.
Publicado: (2023)

Predictors of central nervous system involvement in diffuse large B-cell lymphoma: a divining rod is wanted
por: Ferreri, Andrés José María
Publicado: (2013)

Ibrutinib in primary central nervous system diffuse large B-cell lymphoma
por: T Low, Justin, et al.
Publicado: (2020)

Impact of Central Nervous System International Prognostic Index on the Treatment of Diffuse Large B Cell Lymphoma
por: Ma'koseh, Mohammad, et al.
Publicado: (2021)

Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma
por: Xu, Tianqi, et al.
Publicado: (2019)

Secondary infiltration of the central nervous system in patients with diffuse large B-cell lymphoma
por: da Rocha, Talita Maira Bueno da Silveira, et al.
Publicado: (2013)

Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence
por: Magnes, T., et al.
Publicado: (2021)

New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study
por: Cai, Qing-Qing, et al.
Publicado: (2016)

Clinical Impact of the Histopathological Index and Neuroimaging Features Status in Primary Central Nervous System Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Analysis of 51 Cases
por: Qi, Zhou, et al.
Publicado: (2022)

Quantitative proteomic analysis of cerebrospinal fluid from patients with diffuse large B-cell lymphoma with central nervous system involvement: A novel approach to diagnosis
por: Liu, Xiaobei, et al.
Publicado: (2019)

Impact of a Faulty Germinal Center Reaction on the Pathogenesis of Primary Diffuse Large B Cell Lymphoma of the Central Nervous System
por: Montesinos-Rongen, Manuel, et al.
Publicado: (2021)

Adrenal relapse of primary central nervous system diffuse large B-cell lymphoma: A case report
por: Ma, Shuang, et al.
Publicado: (2018)

Single-cell transcriptome analysis of diffuse large B cells in cerebrospinal fluid of central nervous system lymphoma
por: Ruan, Haoyu, et al.
Publicado: (2021)

MYC Protein Expression in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
por: Gill, Kamraan Z., et al.
Publicado: (2014)

Central nervous system prophylaxis in diffuse large B-cell lymphoma: a race to the bottom
por: Roschewski, Mark
Publicado: (2021)

Immune Checkpoint Molecules in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
por: Monabati, Ahmad, et al.
Publicado: (2020)

Single-cell landscape of primary central nervous system diffuse large B-cell lymphoma
por: Liu, Nianping, et al.
Publicado: (2023)

Acute Encephalitis in an Adult with Diffuse Large B-Cell Lymphoma with Secondary Involvement of the Central Nervous System: Infectious or Non-Infectious Etiology?
por: Moonga, Surinder S., et al.
Publicado: (2017)

BCL-2 and MYC gain/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phase
por: Zou, Dehui, et al.
Publicado: (2017)

Optical Coherence Tomography Benefits the Diagnosis and Follow-Up of Primary Central Nervous System Lymphoma with Intraocular Involvement
por: Zhou, Xianjin, et al.
Publicado: (2022)

Primary Diffuse Large B-Cell Lymphoma of Central Nervous System: Is Still Surgery an Unorthodox Treatment?
por: Siasios, Ioannis, et al.
Publicado: (2015)

Advances in risk assessment and prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma
por: Qualls, David, et al.
Publicado: (2019)

Preventing central nervous system spread in diffuse large B-cell lymphoma – novel approaches needed
por: Roschewski, Mark
Publicado: (2021)

Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma
por: Isaev, Keren, et al.
Publicado: (2020)

P1179: EFFECTIVENESS OF CENTRAL NERVOUS SYSTEM PROPHYLAXIS STRATEGIES IN DIFFUSE LARGE B-CELL LYMPHOMA
por: Eraslan, F. Z., et al.
Publicado: (2022)

Clinicopathological features of primary central nervous system diffuse large B cell lymphoma: Experience from a Tertiary Center in North India
por: Radotra, Bishan Dass, et al.
Publicado: (2020)

Delayed Contrast Enhancement in Magnetic Resonance Imaging and Vascular Morphology of Primary Diffuse Large B-Cell Lymphoma (DLBCL) of the Central Nervous System (CNS): A Retrospective Study
por: Liu, Dandan, et al.
Publicado: (2019)

Evaluation and Application of Population Pharmacokinetic Models for Identifying Delayed Methotrexate Elimination in Patients With Primary Central Nervous System Lymphoma
por: Mao, Junjun, et al.
Publicado: (2022)

Effectiveness of digital PCR for MYD88(L265P) detection in vitreous fluid for primary central nervous system lymphoma diagnosis
por: Chen, Kun, et al.
Publicado: (2020)

Influence of Hyperglycemia on the Prognosis of Patients with Diffuse Large B-Cell Lymphoma
por: Zhou, Weiling, et al.
Publicado: (2022)

A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma
por: Cheah, C Y, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_je4e2464sao091n1sh0bmqpo5d